VMD mentioned in Cove Capital Q3 investors letter Per Cove Capital Q3 investor letter - (released before earnings....)
"While the core offerings of Viemed Healthcare (Ticker: VMD) enable an efficient, at-home service to increasingly ill patients that facilitates breathing and allows them to avoid visits to the ER. That apparently is a not view shared by some large Medicare Advantage (MA) plans. In particular, there has been a recent trend towards elevated denial rates for non-invasive ventilation (NIV), as high as mid-80s for under one large MA plan and the mid60s for a couple other large MA plans. These rates are aggressive relative to many other MA plans that have as low as mid-teens denial rates. In the shortterm, these denial rates have put some pressure on the stock, but despite these issues, Viemed continues to profitably grow as well as acquire other NIV providers."
Bestobe Note:Reference to aquiring other companies might be on hold for awhile after listening to CC...don't you think?